World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
41
Citations
7034
World Ranking
5429
National Ranking
2051

Gale Smith publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Gale Smith sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 69 publications — 1st percentile

1% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Gale Smith D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Gale Smith sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 41 D-Index — 2nd percentile

2% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Gale Smith is affiliated with Novavax in the United States and has contributed extensively to research in infectious diseases, particularly focusing on SARS-CoV-2 and COVID-19. Their work spans multiple subfields including epidemiology, animal science and zoology, immunology, and molecular biology, reflecting a comprehensive approach to understanding viral infections and immune responses.

The primary topics of Gale Smith's research include:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Animal Virus Infections Studies
  • Influenza Virus Research Studies
  • Viral gastroenteritis research and epidemiology
  • Immunotherapy and Immune Responses
  • Respiratory viral infections research

Recent publications highlight Smith's involvement in vaccine development and immunogenicity studies. Notable papers include:

  • "Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine" (2020), published in the New England Journal of Medicine
  • "SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice" (2021), published in Nature Communications
  • "SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines" (2021), published in Cell Host & Microbe
  • "Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate" (2020), published in Science
  • "NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge" (2020), published in Vaccine

Smith frequently collaborates with several researchers, with the most common coauthors being Nita Patel, Gregory M. Glenn, Mimi Guebre-Xabier, Bin Zhou, and Michael J. Massare. This network indicates a strong collaborative environment in the field of vaccine research and virus immunology.

The scientist's publications are predominantly found in several key venues known for infectious disease and vaccine research, including bioRxiv (Cold Spring Harbor Laboratory), Nature Communications, Vaccine, Vaccines, and the New England Journal of Medicine.

With over 100 publications in the medical field and a notable emphasis on infectious diseases, Smith's work contributes to the understanding of viral infection mechanisms and vaccine efficacy. Their research addresses both preclinical and clinical aspects of viral immunogenicity and vaccine development, particularly targeting the SARS-CoV-2 virus and its variants.

Best Publications

  • SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice.

    Jing Hui Tian;Nita Patel;Robert Haupt;Haixia Zhou

  • Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice.

    Peter Pushko;Terrence M. Tumpey;Fang Bu;John Knell

  • Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate.

    Sandhya Bangaru;Gabriel Ozorowski;Hannah L Turner;Aleksandar Antanasijevic

  • SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines.

    Xiaoying Shen;Haili Tang;Charlene McDanal;Kshitij Wagh

  • Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.

    Rick A. Bright;Donald M. Carter;Shannon Daniluk;Franklin R. Toapanta

  • Purified coronavirus Spike protein nanoparticles induce coronavirus neutralizing antibodies in mice

    Christopher M. Coleman;Ye V. Liu;Haiyan Mu;Justin K. Taylor

  • Cross-Clade Protective Immune Responses to Influenza Viruses with H5N1 HA and NA Elicited by an Influenza Virus-Like Particle

    Rick A. Bright;Donald M. Carter;Corey J. Crevar;Franklin R. Toapanta

  • Baculovirus-derived hemagglutinin vaccines protect against lethal influenza infections by avian H5 and H7 subtypes.

    John Crawford;Bethanie Wilkinson;Andrei Vosnesensky;Gale Smith

  • The Safety and Immunogenicity of a Human Immunodeficiency Virus Type 1 (HIV-1) Recombinant gp160 Candidate Vaccine in Humans

    Raphael Dolin;Barney S. Graham;Stephen B. Greenberg;Carol O. Tacket

  • Respiratory syncytial virus fusion glycoprotein expressed in insect cells form protein nanoparticles that induce protective immunity in cotton rats.

    Gale Smith;Rama Raghunandan;Yingyun Wu;Ye Liu

  • A Randomized, Blinded, Controlled, Dose-Ranging Study of a Respiratory Syncytial Virus Recombinant Fusion (F) Nanoparticle Vaccine in Healthy Women of Childbearing Age

    Gregory M. Glenn;Louis F. Fries;D. Nigel Thomas;Gale Smith

  • Induction of CD4+ human cytolytic T cells specific for HIV-infected cells by a gp160 subunit vaccine

    Rimas J. Orentas;James E K Hildreth;Eugene Obah;Michael J Polydefkis

  • Safety and immunogenicity of a Sf9 insect cell-derived respiratory syncytial virus fusion protein nanoparticle vaccine

    Gregory M. Glenn;Gale Smith;Louis Fries;Rama Raghunandan

  • Newcastle disease virus-like particles containing respiratory syncytial virus G protein induced protection in BALB/c mice, with no evidence of immunopathology.

    Matthew R. Murawski;Lori W. McGinnes;Robert W. Finberg;Evelyn A. Kurt-Jones

  • Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine in a blinded, randomized, placebo-controlled trial of adults in Mexico.

    Constantino López-Macías;Eduardo Ferat-Osorio;Alejandra Tenorio-Calvo;Alejandra Tenorio-Calvo;Armando Isibasi

  • Intranasal Vaccination with 1918 Influenza Virus-Like Particles Protects Mice and Ferrets from Lethal 1918 and H5N1 Influenza Virus Challenge

    Lucy A. Perrone;Attiya Ahmad;Vic Veguilla;Xiuhua Lu

  • Pharmacological administration of granulocyte/macrophage-colony-stimulating factor is of significant importance for the induction of a strong humoral and cellular response in patients immunized with recombinant carcinoembryonic antigen.

    Ali Samanci;Qing Yi;Jan Fagerberg;Karin Strigård

  • Development of influenza H7N9 virus like particle (VLP) vaccine: homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus.

    Gale E. Smith;David C. Flyer;Ramadevi Raghunandan;Ye Liu

  • Assembly and Immunological Properties of Newcastle Disease Virus-Like Particles Containing the Respiratory Syncytial Virus F and G Proteins

    Lori W. McGinnes;Kathryn A. Gravel;Robert W. Finberg;Evelyn A. Kurt-Jones

  • Matrix-M adjuvant enhances antibody, cellular and protective immune responses of a Zaire Ebola/Makona virus glycoprotein (GP) nanoparticle vaccine in mice.

    Karin Lövgren Bengtsson;Haifeng Song;Linda Stertman;Ye Liu

  • Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M vaccination.

    Matthew J. Gorman;Nita Patel;Mimi Guebre-Xabier;Alex L. Zhu;Alex L. Zhu

  • SARS-CoV-2 Variant B.1.1.7 is Susceptible to Neutralizing Antibodies Elicited by Ancestral Spike Vaccines

    Xiaoying Shen;Haili Tang;Charlene McDanal;Kshitij Wagh

Frequent Co-Authors

L F Fries
L F Fries Novavax (United States)
Matthew B. Frieman
Matthew B. Frieman University of Maryland, Baltimore
David C. Montefiori
David C. Montefiori Duke University
Terrence M. Tumpey
Terrence M. Tumpey Centers for Disease Control and Prevention
Richard W. Compans
Richard W. Compans Emory University
Pedro A. Piedra
Pedro A. Piedra Baylor College of Medicine
Jay W. Hooper
Jay W. Hooper United States Department of the Army
Fatima Amanat
Fatima Amanat Icahn School of Medicine at Mount Sinai

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to various interdisciplinary career paths, especially in the healthcare sector. One growing field is health information management, which combines knowledge of healthcare and data to improve patient outcomes. Understanding the health information management salary entry-level landscape is vital for students exploring this route, as it offers competitive pay and strong job growth.

For those interested in advancing their career online, numerous online health information management degree programs cahiim accredited provide flexible learning options with recognized certifications. These programs are designed to meet industry standards and prepare students for certification exams.

Alternatively, if you seek a fast-paced entry point into healthcare administration, consider certificate options like the fast track medical billing and coding certificate online. These programs offer efficient paths to gain essential skills for supporting medical offices and clinics.

Beyond these, a range of online healthcare programs are available, providing diverse opportunities to specialize and upskill while balancing personal commitments.

Best Scientists Citing Gale Smith

Trending Scientists

Recently Published Articles